Human PC3 Prostate Adenocarcinoma Cells

Human PC3 Prostate Adenocarcinoma Cells are a highly regarded cell line that originates from metastatic prostate carcinoma. Known for their aggressive nature, these cells exhibit rapid proliferation and possess a significant tumorigenic potential, making them a valuable resource in cancer research.

One of the key features of PC3 cells is their androgen-independent phenotype, which allows them to thrive without the typical hormonal stimuli that influence prostate cancer growth.

Due to these characteristics, PC3 cells are extensively utilized as a model to investigate various aspects of prostate cancer, including disease progression and the mechanisms underlying metastasis. Researchers also use these cells to delve into tumor biology, examining cellular behavior, gene expression, and signaling pathways.

Furthermore, PC3 cells play a crucial role in drug response studies, enabling scientists to evaluate the efficacy of new therapeutic agents and screen potential anticancer compounds in a controlled, in vitro environment.

IMPORTANT: Quality warranty requires use of NeoBioPharma media. Biohazardous material despite negative pathogen testing. Quality claims must be reported within 1 month.